Cleared Special

K201487 - Traxcess 7 Mini Guidewire

K201487 is the FDA 510(k) clearance for Traxcess 7 Mini Guidewire by MicroVention, Inc.. It is a Class 2 Neurology device (product code MOF) cleared through the Special 510(k) pathway after a 28-day FDA review.

K201487 · MicroVention, Inc. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2020
Decision
28d
Days
Class 2
Risk

K201487 is an FDA 510(k) clearance for the Traxcess 7 Mini Guidewire. Classified as Guide, Wire, Catheter, Neurovasculature (product code MOF), Class II - Special Controls.

Submitted by MicroVention, Inc. (Aliso Viejo, US). The FDA issued a Cleared decision on July 2, 2020 after a review of 28 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 870.1330 - the FDA neurology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all MicroVention, Inc. devices

Submission Details

510(k) Number K201487 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 04, 2020
Decision Date July 02, 2020
Days to Decision 28 days
Submission Type Special
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
120d faster than avg
Panel avg: 148d · This submission: 28d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code MOF Guide, Wire, Catheter, Neurovasculature
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1330
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - MOF Guide, Wire, Catheter, Neurovasculature

All 38
Devices cleared under the same product code (MOF) and FDA review panel - the closest regulatory comparables to K201487.
RADIFOCUS Torque Device
K220934 · Terumo Medical Products Hangzhou Co., Ltd. · Jun 2022
Columbus Guidewire
K200374 · Rapid Medical , Ltd. · Dec 2020
Synchro SELECT Guidewire
K202522 · Stryker Neurovascular · Sep 2020
Traxcess 14 SELECT Guidewire
K200547 · MicroVention, Inc. · Apr 2020
ASAHI Neurovascular Guide Wire CHIKAI X 014 soft
K191714 · Asahi Intecc Co., Ltd. · Jul 2019
Synchro2 Support Guidewire
K190843 · Stryker · May 2019